AIHC Capital Management Ltd
Follow13F filer, CIK 2103725, CENTRAL, Hong Kong
AIHC Capital Management Ltd reported $108,685,317 across 6 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.
Accepted , ingested 13F-HR 0001172661-26-005109
- Period
- 2026-09-30
- Reported value
- $109M
- Holdings
- 6
- Top 10 weight
- 100%
- New
- 2
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| LEGNnew | +1,182,389 | $23.5M |
| ORICadded | +802,526 | $10.8M |
| KURAnew | +139,673 | $1.5M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| RVMDreduced | -220,000 | -$45.2M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0001172661-26-005109, largest first. % of portfolio is the value over $108,685,317, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ORICORIC PHARMACEUTICALS INC | 4,630,986 | $62.4M | 57.39% | +802,526 | Timeline | ||
| LEGNLEGEND BIOTECH CORP | 1,182,389 | $23.5M | 21.64% | new | Timeline | ||
| RVMDREVOLUTION MEDICINES INC | 83,133 | $17.1M | 15.7% | -220,000 | Timeline | ||
| NBPNOVABRIDGE BIOSCIENCES | 2,878,033 | $3.93M | 3.61% | 0 | Timeline | ||
| KURAKURA ONCOLOGY INC | 139,673 | $1.5M | 1.38% | new | Timeline | ||
| KRROKORRO BIO INC | 30,265 | $300K | 0.28% | 0 | Timeline |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001172661-26-005109 | base | 2026-11-16 |